EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease.

LEVY, Antonin; HENDRIKS, Lizza; Berghmans, Thierry; Faivre-Finn, Corinne; Giaj-Levra, Matteo; Giaj-Levra, Niccolò; Hasan, Baktiar; Pochesci, Alessia; Girard, Nicolas; Greillier, Laurent; Lantuejoul, Sylvie; Edwards, Christopher John; Brien, Mary O‘; Reck, Martin; Besse, Benjamin; Novello, Silvia; Dingemans, Anne-Marie C; European Organisation for Research and Treatment of Cancer (EORTC) Lung Cancer Group

oai:dipot.ulb.ac.be:2013/295183

EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease.

Authors: Antonin LEVY
Lizza HENDRIKS
Thierry Berghmans
Corinne Faivre-Finn
Matteo Giaj-Levra
Niccolò Giaj-Levra
Baktiar Hasan
Alessia Pochesci
Nicolas Girard
Laurent Greillier
Sylvie Lantuejoul
Christopher John Edwards
Mary O‘ Brien
Martin Reck
Benjamin Besse
Silvia Novello
Anne-Marie C Dingemans
European Organisation for Research and Treatment of Cancer (EORTC) Lung Cancer Group
Publication date: 1 October 2019
Publisher
Doi

Abstract

Synchronous oligometastatic disease (sOM) has been described as a distinct disease entity; however, there is no consensus on OM definition (OM-d) in non-small-cell lung cancer (NSCLC). A consensus group was formed aiming to agree on a common OM-d that could be used in future clinical trials. A European survey was circulated to generate questions and input for the consensus group meeting.info:eu-repo/semantics/publishe

Similar works

Full text

DI-fusion

oai:dipot.ulb.ac.be:2013/29518...

Last time updated on 20/11/2019

This paper was published in DI-fusion.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.